LBF20207PG50: Difference between revisions

No edit summary
No edit summary
Line 5: Line 5:
|LipidMaps=LMFA03010094
|LipidMaps=LMFA03010094
|SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid
|SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid
|Common Name=&&15-epi-prostaglandin E2 acetate, methyl ester&&
|Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester&&
}}
}}

Revision as of 07:38, 19 December 2008


Upper classes: LB LBF



15-epi-prostaglandin E2acetate, methyl ester
LBF20207PG50.png
Structural Information
(5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid
  • 15-epi-prostaglandin E2acetate, methyl ester
Formula C20H32O5
Exact Mass 352.224974134
Average Mass 352.46508
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC
Physicochemical Information
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG50 See above. Light_RJ et al. 1972